The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bifidobacterium Longum Market Research Report 2025
Synopsis
Bifidobacterium longum is a species of small pathogenic bacteria, which naturally occurs in gastrointestinal tracts of human and other animals. The bacterium is added to different types of foods, beverages, and dietary supplements as a probiotic, as it provides many health benefits such as improved digestion and bowel movements.
The global Bifidobacterium Longum market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bifidobacterium Longum is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bifidobacterium Longum is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bifidobacterium Longum include ATCC Inc, BioGaia AB, Mystic Pharmaceuticals Inc, Hanson Ltd, Biofodan A/S, BioCare Copenhagen ApS, Danisco A/S, Danone SA and Deerland Enzymes Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bifidobacterium Longum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bifidobacterium Longum.
Report Scope
The Bifidobacterium Longum market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bifidobacterium Longum market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bifidobacterium Longum manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ATCC Inc
BioGaia AB
Mystic Pharmaceuticals Inc
Hanson Ltd
Biofodan A/S
BioCare Copenhagen ApS
Danisco A/S
Danone SA
Deerland Enzymes Inc.
Segment by Type
0.2g/Piece
0.25g/Piece
Segment by Application
Medicine
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bifidobacterium Longum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bifidobacterium Longum in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Bifidobacterium longum is a species of small pathogenic bacteria, which naturally occurs in gastrointestinal tracts of human and other animals. The bacterium is added to different types of foods, beverages, and dietary supplements as a probiotic, as it provides many health benefits such as improved digestion and bowel movements.
The global Bifidobacterium Longum market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bifidobacterium Longum is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bifidobacterium Longum is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bifidobacterium Longum include ATCC Inc, BioGaia AB, Mystic Pharmaceuticals Inc, Hanson Ltd, Biofodan A/S, BioCare Copenhagen ApS, Danisco A/S, Danone SA and Deerland Enzymes Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bifidobacterium Longum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bifidobacterium Longum.
Report Scope
The Bifidobacterium Longum market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bifidobacterium Longum market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bifidobacterium Longum manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ATCC Inc
BioGaia AB
Mystic Pharmaceuticals Inc
Hanson Ltd
Biofodan A/S
BioCare Copenhagen ApS
Danisco A/S
Danone SA
Deerland Enzymes Inc.
Segment by Type
0.2g/Piece
0.25g/Piece
Segment by Application
Medicine
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bifidobacterium Longum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bifidobacterium Longum in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bifidobacterium Longum Market Overview
1.1 Product Overview and Scope of Bifidobacterium Longum
1.2 Bifidobacterium Longum Segment by Type
1.2.1 Global Bifidobacterium Longum Market Value Comparison by Type (2024-2030)
1.2.2 0.2g/Piece
1.2.3 0.25g/Piece
1.3 Bifidobacterium Longum Segment by Application
1.3.1 Global Bifidobacterium Longum Market Value by Application: (2024-2030)
1.3.2 Medicine
1.3.3 Others
1.4 Global Bifidobacterium Longum Market Size Estimates and Forecasts
1.4.1 Global Bifidobacterium Longum Revenue 2019-2030
1.4.2 Global Bifidobacterium Longum Sales 2019-2030
1.4.3 Global Bifidobacterium Longum Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bifidobacterium Longum Market Competition by Manufacturers
2.1 Global Bifidobacterium Longum Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bifidobacterium Longum Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bifidobacterium Longum Average Price by Manufacturers (2019-2024)
2.4 Global Bifidobacterium Longum Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bifidobacterium Longum, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bifidobacterium Longum, Product Type & Application
2.7 Bifidobacterium Longum Market Competitive Situation and Trends
2.7.1 Bifidobacterium Longum Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bifidobacterium Longum Players Market Share by Revenue
2.7.3 Global Bifidobacterium Longum Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bifidobacterium Longum Retrospective Market Scenario by Region
3.1 Global Bifidobacterium Longum Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bifidobacterium Longum Global Bifidobacterium Longum Sales by Region: 2019-2030
3.2.1 Global Bifidobacterium Longum Sales by Region: 2019-2024
3.2.2 Global Bifidobacterium Longum Sales by Region: 2025-2030
3.3 Global Bifidobacterium Longum Global Bifidobacterium Longum Revenue by Region: 2019-2030
3.3.1 Global Bifidobacterium Longum Revenue by Region: 2019-2024
3.3.2 Global Bifidobacterium Longum Revenue by Region: 2025-2030
3.4 North America Bifidobacterium Longum Market Facts & Figures by Country
3.4.1 North America Bifidobacterium Longum Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bifidobacterium Longum Sales by Country (2019-2030)
3.4.3 North America Bifidobacterium Longum Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bifidobacterium Longum Market Facts & Figures by Country
3.5.1 Europe Bifidobacterium Longum Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bifidobacterium Longum Sales by Country (2019-2030)
3.5.3 Europe Bifidobacterium Longum Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bifidobacterium Longum Market Facts & Figures by Country
3.6.1 Asia Pacific Bifidobacterium Longum Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bifidobacterium Longum Sales by Country (2019-2030)
3.6.3 Asia Pacific Bifidobacterium Longum Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bifidobacterium Longum Market Facts & Figures by Country
3.7.1 Latin America Bifidobacterium Longum Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bifidobacterium Longum Sales by Country (2019-2030)
3.7.3 Latin America Bifidobacterium Longum Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bifidobacterium Longum Market Facts & Figures by Country
3.8.1 Middle East and Africa Bifidobacterium Longum Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bifidobacterium Longum Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bifidobacterium Longum Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bifidobacterium Longum Sales by Type (2019-2030)
4.1.1 Global Bifidobacterium Longum Sales by Type (2019-2024)
4.1.2 Global Bifidobacterium Longum Sales by Type (2025-2030)
4.1.3 Global Bifidobacterium Longum Sales Market Share by Type (2019-2030)
4.2 Global Bifidobacterium Longum Revenue by Type (2019-2030)
4.2.1 Global Bifidobacterium Longum Revenue by Type (2019-2024)
4.2.2 Global Bifidobacterium Longum Revenue by Type (2025-2030)
4.2.3 Global Bifidobacterium Longum Revenue Market Share by Type (2019-2030)
4.3 Global Bifidobacterium Longum Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bifidobacterium Longum Sales by Application (2019-2030)
5.1.1 Global Bifidobacterium Longum Sales by Application (2019-2024)
5.1.2 Global Bifidobacterium Longum Sales by Application (2025-2030)
5.1.3 Global Bifidobacterium Longum Sales Market Share by Application (2019-2030)
5.2 Global Bifidobacterium Longum Revenue by Application (2019-2030)
5.2.1 Global Bifidobacterium Longum Revenue by Application (2019-2024)
5.2.2 Global Bifidobacterium Longum Revenue by Application (2025-2030)
5.2.3 Global Bifidobacterium Longum Revenue Market Share by Application (2019-2030)
5.3 Global Bifidobacterium Longum Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ATCC Inc
6.1.1 ATCC Inc Corporation Information
6.1.2 ATCC Inc Description and Business Overview
6.1.3 ATCC Inc Bifidobacterium Longum Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ATCC Inc Bifidobacterium Longum Product Portfolio
6.1.5 ATCC Inc Recent Developments/Updates
6.2 BioGaia AB
6.2.1 BioGaia AB Corporation Information
6.2.2 BioGaia AB Description and Business Overview
6.2.3 BioGaia AB Bifidobacterium Longum Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BioGaia AB Bifidobacterium Longum Product Portfolio
6.2.5 BioGaia AB Recent Developments/Updates
6.3 Mystic Pharmaceuticals Inc
6.3.1 Mystic Pharmaceuticals Inc Corporation Information
6.3.2 Mystic Pharmaceuticals Inc Description and Business Overview
6.3.3 Mystic Pharmaceuticals Inc Bifidobacterium Longum Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mystic Pharmaceuticals Inc Bifidobacterium Longum Product Portfolio
6.3.5 Mystic Pharmaceuticals Inc Recent Developments/Updates
6.4 Hanson Ltd
6.4.1 Hanson Ltd Corporation Information
6.4.2 Hanson Ltd Description and Business Overview
6.4.3 Hanson Ltd Bifidobacterium Longum Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hanson Ltd Bifidobacterium Longum Product Portfolio
6.4.5 Hanson Ltd Recent Developments/Updates
6.5 Biofodan A/S
6.5.1 Biofodan A/S Corporation Information
6.5.2 Biofodan A/S Description and Business Overview
6.5.3 Biofodan A/S Bifidobacterium Longum Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biofodan A/S Bifidobacterium Longum Product Portfolio
6.5.5 Biofodan A/S Recent Developments/Updates
6.6 BioCare Copenhagen ApS
6.6.1 BioCare Copenhagen ApS Corporation Information
6.6.2 BioCare Copenhagen ApS Description and Business Overview
6.6.3 BioCare Copenhagen ApS Bifidobacterium Longum Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BioCare Copenhagen ApS Bifidobacterium Longum Product Portfolio
6.6.5 BioCare Copenhagen ApS Recent Developments/Updates
6.7 Danisco A/S
6.6.1 Danisco A/S Corporation Information
6.6.2 Danisco A/S Description and Business Overview
6.6.3 Danisco A/S Bifidobacterium Longum Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Danisco A/S Bifidobacterium Longum Product Portfolio
6.7.5 Danisco A/S Recent Developments/Updates
6.8 Danone SA
6.8.1 Danone SA Corporation Information
6.8.2 Danone SA Description and Business Overview
6.8.3 Danone SA Bifidobacterium Longum Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Danone SA Bifidobacterium Longum Product Portfolio
6.8.5 Danone SA Recent Developments/Updates
6.9 Deerland Enzymes Inc.
6.9.1 Deerland Enzymes Inc. Corporation Information
6.9.2 Deerland Enzymes Inc. Description and Business Overview
6.9.3 Deerland Enzymes Inc. Bifidobacterium Longum Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Deerland Enzymes Inc. Bifidobacterium Longum Product Portfolio
6.9.5 Deerland Enzymes Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bifidobacterium Longum Industry Chain Analysis
7.2 Bifidobacterium Longum Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bifidobacterium Longum Production Mode & Process
7.4 Bifidobacterium Longum Sales and Marketing
7.4.1 Bifidobacterium Longum Sales Channels
7.4.2 Bifidobacterium Longum Distributors
7.5 Bifidobacterium Longum Customers
8 Bifidobacterium Longum Market Dynamics
8.1 Bifidobacterium Longum Industry Trends
8.2 Bifidobacterium Longum Market Drivers
8.3 Bifidobacterium Longum Market Challenges
8.4 Bifidobacterium Longum Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
